Printer Friendly
The Free Library
14,716,402 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Isentress (Raltegravir) pricing: community sign-on letter.


The Fair Pricing Coalition is asking Merck to price its new and very important integrase inhibitor Integrase inhibitors are a class of antiretroviral drug developed for the treatment of HIV infection, although they are not necessarily limited to HIV treatment. They block the action of integrase, an enzyme that integrates genetic material from the virus into its target cell.  at a level everyone can live with. The letter is seeking organization and individual signers until the official launch of the drug, when the price will be announced.

"A new HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  drug produced by Merck is about to be approved by the Food & Drug Administration in early October. While this is great news, especially for people who have developed resistance to existing therapies, the pricing of this treatment will have a major impact on the various publicly funded programs like Medicaid Medicaid, national health insurance program in the United States for low-income persons; established in 1965 with passage of the Social Security Amendments and now run by the Centers for Medicare and Medicaid Services. , Medicare Medicare, national health insurance program in the United States for persons aged 65 and over and the disabled. It was established in 1965 with passage of the Social Security Amendments and is now run by the Centers for Medicare and Medicaid Services. , and the AIDS Drug Assistance Program, all of which are already straining at the breaking point.

"Please join the Fair Pricing Coalition by signing onto the following statement to Merck...."

For the text of the letter and instructions for signing, visit http://www.aidsnews.org/now/2007/09/pricing-of-new-hiv-drug-threatens.html
COPYRIGHT 2007 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:AIDS Treatment News
Date:Jul 1, 2007
Words:148
Previous Article:New kind of antiretroviral, KP-1461; clinical trial recruiting. interview with Stephen Becker, M.D.(Interview)
Next Article:AIDS Treatment News new toll-free phone number, 800-804-8845.
Topics:



Related Articles
Community case of methicillin-resistant Staphylococcus aureus infection.(LETTERS)
Community-associated Methicillin-resistant Staphylococcus aureus.(LETTERS)(Letter to the editor)
In vicious diatribe, Latvian cardinal distorts catholic teachings on homosexuality.(The Church and Homosexuality)
Certified coffee does the premium Pay off?(Spheres of Influence)
The war for the woods.(ECONOMICALLY SPEAKING)
2007 City of Greater Sudbury's annual check-up.(NEWS)
T-Bay chamber acts as election watchdog.(IN BRIEF)
Junior becomes miner with North Shore project.(SPECIAL REPORT: MINING)
Happy diamond mining for De Beers and Moose Cree.(IN BRIEF)
Wanna Start on Collecting Coins? A Worthwhile and Educational Hobby

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles